Skip to main content
Log in

Cardiovascular and renal effects of acute administration of a new hypotensive compound, guancydine

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Oral administration of a single 500 mg dose of guancydine rapidly (30 mins) produces a marked fall in systolic and diastolic blood pressure, which lasts for at least 6 h, and is accompanied by tachycardia. Hypotension and tachycardia are more marked on standing, but conspicuous postural falls seldom occur. The decrease in blood pressure does not depend on angiotensin antagonism by guancydine, as pressor responses to angiotensin, as well as to noradrenaline, are not diminished by the drug. Marked fluid and electrolyte retention also occurs after guancydine administration, and is probably due to a reduction in glomerular filtration rate and increased tubular reabsorption of sodium. The time course of the various effects of guancydine closely parallels changes in the plasma concentration of the drug. A very precise quantitative relationship exists between the hypotensive effect and the log of plasma guancydine concentrations between 1 and 5 µg/ml.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bartorelli, C., Gargano, N., Leonetti, G., Zanchetti, A.: Hypotensive and renal effects of diazoxide, a sodium retaining benzothiadiazine compound. Circulation27, 895–903 (1963).

    Google Scholar 

  2. Cummings, J.R., Grace, J.L., Jr.: Loss of guancydine's angiotensin inhibitory action in nephrectomized rats and reestablishment of blockade by cross circulation. Pharmacologist11, 270 (1969).

    Google Scholar 

  3. —— Welter, A.N., Grace, J.L., Jr., Gray, W. D.: Angiotensin blocking actions of guancydine. J. Pharmacol. exp. Ther.170, 334–346 (1969).

    Google Scholar 

  4. —— —— —— Lipchuck, L.M.: Cardiovascular actions of guancydine in normotensive and hypertensive animals. J. Pharmacol. exp. Ther.161, 88–97 (1968).

    Google Scholar 

  5. Freis, E.D., Hammer, J.: Guancydine, a new type of antihypertensive agent. Med. Ann. D.C.38, 69–72 (1969).

    Google Scholar 

  6. Gussin, R.Z., Stokey, E.H., Ronsberg, M.A., Malone, L.C.: Mechanisms of antihypertensive-induced fluid retention. Clin. Res.18, 500 (1970).

    Google Scholar 

  7. Leonetti, G., Grazi, S., Ligresti, A., Romano, S., Zanchetti, A.: Autonomic and renal effects of intravenous diazoxide. A study of the mechanisms of its hypertensive action in man. Europ. J. clin. Pharmacol.2, 206–215 (1970).

    Google Scholar 

  8. -- Porro, T., Zanchetti, A.: Hypotensive and renal effects of repeated administration of a new antihypertensive agent, guancydine. In preparation.

  9. Onesti, G., Schwartz, A.B., Kim, K.E., Swartz, C., Brest, A.N.: Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155). Circulation39, 219–228 (1969).

    Google Scholar 

  10. Snedecor, G.W., Cochran, W.G.: Statistical methods. Sixth Edition. Ames (Iowa): The Iowa State University Press 1967.

    Google Scholar 

  11. Stenberg, J., Sannerstedt, R., Werkö, L.: Haemodynamic studies on the antihypertensive effect of guancydine. Europ. J. clin. Pharmacol.3, 63–67 (1971).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leonetti, G., Bonazzi, O., Grazi, S. et al. Cardiovascular and renal effects of acute administration of a new hypotensive compound, guancydine. Eur J Clin Pharmacol 4, 1–9 (1971). https://doi.org/10.1007/BF00568890

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00568890

Key words

Navigation